149 related articles for article (PubMed ID: 38072809)
1. In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism.
Billingsley MM; Gong N; Mukalel AJ; Thatte AS; El-Mayta R; Patel SK; Metzloff AE; Swingle KL; Han X; Xue L; Hamilton AG; Safford HC; Alameh MG; Papp TE; Parhiz H; Weissman D; Mitchell MJ
Small; 2024 Mar; 20(11):e2304378. PubMed ID: 38072809
[TBL] [Abstract][Full Text] [Related]
2. Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
Billingsley MM; Singh N; Ravikumar P; Zhang R; June CH; Mitchell MJ
Nano Lett; 2020 Mar; 20(3):1578-1589. PubMed ID: 31951421
[TBL] [Abstract][Full Text] [Related]
3. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta.
Geisler HC; Ghalsasi AA; Safford HC; Swingle KL; Thatte AS; Mukalel AJ; Gong N; Hamilton AG; Han EL; Nachod BE; Padilla MS; Mitchell MJ
J Control Release; 2024 May; ():. PubMed ID: 38789090
[TBL] [Abstract][Full Text] [Related]
4. Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells.
Prazeres PHDM; Ferreira H; Costa PAC; da Silva W; Alves MT; Padilla M; Thatte A; Santos AK; Lobo AO; Sabino A; Del Puerto HL; Mitchell MJ; Guimaraes PPG
Int J Nanomedicine; 2023; 18():5891-5904. PubMed ID: 37873551
[TBL] [Abstract][Full Text] [Related]
5. Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells.
Billingsley MM; Hamilton AG; Mai D; Patel SK; Swingle KL; Sheppard NC; June CH; Mitchell MJ
Nano Lett; 2022 Jan; 22(1):533-542. PubMed ID: 34669421
[TBL] [Abstract][Full Text] [Related]
6. CAR T cells produced in vivo to treat cardiac injury.
Rurik JG; Tombácz I; Yadegari A; Méndez Fernández PO; Shewale SV; Li L; Kimura T; Soliman OY; Papp TE; Tam YK; Mui BL; Albelda SM; Puré E; June CH; Aghajanian H; Weissman D; Parhiz H; Epstein JA
Science; 2022 Jan; 375(6576):91-96. PubMed ID: 34990237
[TBL] [Abstract][Full Text] [Related]
7. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
Patel SK; Billingsley MM; Mukalel AJ; Thatte AS; Hamilton AG; Gong N; El-Mayta R; Safford HC; Merolle M; Mitchell MJ
Theranostics; 2024; 14(1):1-16. PubMed ID: 38164140
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering.
Kitte R; Rabel M; Geczy R; Park S; Fricke S; Koehl U; Tretbar US
Mol Ther Methods Clin Dev; 2023 Dec; 31():101139. PubMed ID: 38027056
[TBL] [Abstract][Full Text] [Related]
9. CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo.
Golubovskaya V; Sienkiewicz J; Sun J; Zhang S; Huang Y; Zhou H; Harto H; Xu S; Berahovich R; Wu L
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686170
[TBL] [Abstract][Full Text] [Related]
10. Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma.
Álvarez-Benedicto E; Tian Z; Chatterjee S; Orlando D; Kim M; Guerrero ED; Wang X; Siegwart DJ
Angew Chem Int Ed Engl; 2023 Oct; 62(44):e202310395. PubMed ID: 37651468
[TBL] [Abstract][Full Text] [Related]
11. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
[TBL] [Abstract][Full Text] [Related]
12. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Engineering Chimeric Antigen Receptor Macrophages and T Cells by Lipid Nanoparticle-Mediated mRNA Delivery.
Ye Z; Chen J; Zhao X; Li Y; Harmon J; Huang C; Chen J; Xu Q
ACS Biomater Sci Eng; 2022 Feb; 8(2):722-733. PubMed ID: 35104103
[TBL] [Abstract][Full Text] [Related]
14. Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery.
Zeng G; He Z; Yang H; Gao Z; Ge X; Liu L; Liu Z; Chen Y
ACS Appl Mater Interfaces; 2024 May; 16(20):25698-25709. PubMed ID: 38717294
[TBL] [Abstract][Full Text] [Related]
15. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.
Patel SK; Billingsley MM; Frazee C; Han X; Swingle KL; Qin J; Alameh MG; Wang K; Weissman D; Mitchell MJ
J Control Release; 2022 Jul; 347():521-532. PubMed ID: 35569584
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs.
Tombácz I; Laczkó D; Shahnawaz H; Muramatsu H; Natesan A; Yadegari A; Papp TE; Alameh MG; Shuvaev V; Mui BL; Tam YK; Muzykantov V; Pardi N; Weissman D; Parhiz H
Mol Ther; 2021 Nov; 29(11):3293-3304. PubMed ID: 34091054
[TBL] [Abstract][Full Text] [Related]
17. Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy.
Metzloff AE; Padilla MS; Gong N; Billingsley MM; Han X; Merolle M; Mai D; Figueroa-Espada CG; Thatte AS; Haley RM; Mukalel AJ; Hamilton AG; Alameh MG; Weissman D; Sheppard NC; June CH; Mitchell MJ
Adv Mater; 2024 Feb; ():e2313226. PubMed ID: 38419362
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects.
Chen J; Xu Y; Zhou M; Xu S; Varley AJ; Golubovic A; Lu RXZ; Wang KC; Yeganeh M; Vosoughi D; Li B
Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2309472120. PubMed ID: 38060560
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
[TBL] [Abstract][Full Text] [Related]
20. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach.
Young RE; Nelson KM; Hofbauer SI; Vijayakumar T; Alameh MG; Weissman D; Papachristou C; Gleghorn JP; Riley RS
Bioact Mater; 2024 Apr; 34():125-137. PubMed ID: 38223537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
